A new Medicare program will give 3 million older adults access to GLP-1 weight loss drugs starting July 1 — but there's a catch

Seniors will need to consider whether the Medicare Bridge program is right for them, as it’s set to expire next year — and ...
HealthDay on MSN

Use hits record high as Medicare opens access to weight-loss drugs

Key Takeaways Current GLP-1 use for weight loss hit 11% of U.S. adults in 2026, survey estimatesA new Medicare pilot launched ...
The Commonwealth Fund

Improving Access to Medicare Home Health Care: Key Policy Considerations

Misaligned payment and quality incentives, Medicare Advantage practices, and workforce constraints can limit Medicare ...

Big Medicare change slashes weight-loss drug costs for eligible seniors

A new Medicare GLP-1 Bridge program offers Wegovy and Zepbound to eligible seniors for $50 a month starting July 1, slashing ...

Medicare pilot program expands access to Wegovy, Zepbound for some seniors

A Medicare pilot program could expand access to GLP-1 weight-loss drugs for millions of seniors while lowering monthly costs ...

Welldoc Goes Live on CMS ACCESS Model as Credentialed Medicare Part B Supplier to Deliver Scalable Digital-First Chronic Care

Welldoc, a leader in AI-powered health technology focused on complex conditions, today announced that it is officially live ...

GLP-1 Use Hits Record High As Medicare Opens Access To Weight-Loss Drugs

That upward trend may accelerate under the Medicare GLP-1 Bridge, a temporary federal program that took effect July 1. Run by ...

GLP-1 Access Program May Enable Affordable Access For Some On Medicare

Some Medicare beneficiaries are getting access to weight loss drugs this month through a so-called Bridge program. But ...

Medicare opens access to GLP-1 weight-loss drugs

Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock are in focus as Medicare offers coverage for GLP-1 weight-loss drugs for ...